SCHEMBL24737201

SCHEMBL24737201

Cc1ccc(-c2ccc3c(c2)c2cc(-c4ccc(C)cc4C)ccc2n3-c2cncc(-n3c4ccc(-c5ccc(C)cc5C)cc4c4cc(-c5ccc(C)cc5C)ccc43)c2-c2cccc(C#N)c2)c(C)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.38
CYP3A4 P08684 3/20 0.38
KDM4E B2RXH2 2/20 0.38
CYP2D6 P10635 2/20 0.38
CYP2C19 P33261 2/20 0.38
CYP11B1 P15538 1/20 0.37
CYP11B2 P19099 1/20 0.37
ELANE P08246 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2B Q13224 1/20 0.36
HSD17B10 Q99714 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
ALDH1A1 P00352 2/20 0.35
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35
CYP2C9 P11712 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21928373 0.96 CYP1A2 (0.36) CYP1A2CYP3A4KDM4ECYP2D6CYP2C19
SCHEMBL24737200 0.93 CYP1A2 (0.38) CYP1A2CYP3A4KDM4ECYP2D6CYP2C19
SCHEMBL21928372 0.91 CYP1A2 (0.36) CYP1A2CYP3A4KDM4ECYP2D6CYP2C19
SCHEMBL21928591 0.90 CYP11B2 (0.39) CYP11B1CYP11B2
SCHEMBL21546982 0.90 ELANE (0.36) CYP1A2CYP3A4KDM4ECYP2D6CYP2C19
SCHEMBL21931699 0.90 CYP1A2 (0.36) CYP1A2CYP3A4KDM4ECYP2D6CYP2C19
SCHEMBL24738564 0.89 CYP11B1 (0.38) CYP1A2CYP3A4KDM4ECYP2D6CYP2C19
SCHEMBL21931707 0.89 IDO1 (0.37) CYP1A2CYP3A4KDM4ECYP11B1CYP11B2
SCHEMBL21929008 0.89 IDO1 (0.40) CYP1A2CYP3A4KDM4ECYP2D6CYP2C19
SCHEMBL21928407 0.88 CYP1A2 (0.42) CYP1A2CYP3A4KDM4ECYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220388960-A1 ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES CYNORA GMBH (DE) 2022-12-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220388960-A1 ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES ALDH1A2, AOX1, CYBA CYP1A2 24/4885CYP3A4 93/4885KDM4E 4010/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.